PHC Holdings
Precision technology solutions in healthcare diagnostics, diabetes management, cell preservation, and healthcare IT.
- CEO / Founder
- Kyoko Deguchi
- Team Size
- 5001-10000
- Stage
- Active
- Total Funding
- $4.2B
- Latest Round
- Private Equity
- Key Investors
- KKR; L Catterton; Mitsui & Co.; Panasonic Corporation; Public Markets
Technology & Products
Key Products
Diabetes management (blood glucose monitoring systems, data linkage solutions), healthcare solutions, life sciences (laboratory systems, life-science instruments, cell preservation), diagnostics (diagnostic equipment, clinical testing services, cancer diagnostics), and healthcare IT.
Technological Advantage
Pioneering 3D cell production technology and leveraging strategic partnerships, such as with Cyfuse, to advance regenerative medicine.
Differentiation
Value Proposition
Offers innovative healthcare solutions that improve patient outcomes and enhance the efficiency of healthcare services.
How They Differentiate
Emphasizes precision technology and a collaborative approach that leverages cross-divisional synergies.
Market & Competition
Target Customers
Healthcare providers, researchers, and patients
Industry Verticals
["Diagnostics","Life Sciences","Healthcare IT","Drug Development"]
Competitors
Fujifilm Healthcare, GE Healthcare, Cerner, Nihon Kohden Corp., Steris, Bio-Rad Laboratories.
Growth & Milestones
Growth Metrics
Experiencing strategic growth through investments and partnerships, with expansion in diagnostics and life sciences.
Major Milestones
["Launch of a new vision and value creation plan under CEO Kay Deguchi","Establishment of Mediford Corporation for non-clinical testing and clinical trials","Initiation of innovative 3D cell production technology collaboration with Cyfuse"]